Hair loss and abnormal shedding (alopecia) are common dermatologic concerns that may reflect physiologic variation, medication effects, nutritional deficits, immune dysregulation, or endocrine and scalp disease. While many people interpret normal shedding as “handfuls,” the clinical task is to determine whether the pattern and rate suggest telogen effluvium, androgenetic alopecia, alopecia areata, scarring alopecias, or traction-related damage. Hair density is determined by follicle number and the balance between anagen (growth) and telogen (rest) phases. Shedding becomes more apparent when a higher proportion of follicles shift into telogen simultaneously or when regrowth is incomplete.
Telogen effluvium is a major cause of diffuse shedding triggered by systemic stressors. The classic mechanism involves a disruption of follicle cycling, with increased transition from anagen to telogen following an inciting event. Common triggers include major illness with fever (e.g., influenza-like syndromes), surgery, rapid weight loss, severe emotional or physical stress, childbirth, and sometimes new medications. The latency is often 2–3 months between the trigger and noticeable shedding, which can help differentiate telogen effluvium from primary pattern hair loss. Stress may contribute through neuroendocrine pathways, including altered cortisol dynamics and inflammatory signaling, which can affect hair follicle stem cell activity and follicular immune privilege.
Hormonal influences are also central. Androgenetic alopecia (pattern hair loss) is driven by genetic sensitivity of follicles to dihydrotestosterone (DHT), a potent androgen metabolite. In genetically susceptible follicles, DHT shortens the anagen phase, miniaturizes terminal hairs into thinner vellus-like hairs, and gradually reduces follicle caliber. This process presents differently by sex: in men, often recession of the temples and vertex thinning; in women, typically diffuse thinning over the crown with relative preservation of the frontal hairline. Conditions such as polycystic ovary syndrome (PCOS), hyperandrogenism, thyroid dysfunction, and postpartum endocrine shifts can exacerbate shedding and pattern changes.
Nutritional and metabolic factors can mimic or compound shedding. Iron deficiency—sometimes with or without anemia—has been associated with increased telogen shedding. Additional contributors include inadequate protein intake, vitamin D deficiency in some populations, and malabsorption syndromes. Hypothyroidism can produce diffuse hair thinning and texture changes, while hyperthyroidism may also accelerate shedding. Addressing these factors often improves regrowth, particularly in telogen effluvium.
Immune-mediated alopecia should be considered when shedding is localized or sudden. Alopecia areata is characterized by abrupt patches of hair loss with potential regrowth and relapse; severity correlates with nail changes and extensive involvement in some cases. Scalp psoriasis, seborrheic dermatitis, chronic folliculitis, and fungal infections can cause inflammation-driven hair shedding, itching, scaling, and sometimes follicular damage. Importantly, scarring (cicatricial) alopecias represent a group of disorders where inflammation destroys follicles irreversibly; early identification and treatment are critical to preserve remaining follicles.
Psychological stress can worsen perceived hair shedding through both physiologic and behavioral pathways. Stress-related dysregulation may influence immune activity and follicle cycling, while anxiety can heighten body-sensing and hair-pulling vigilance, leading to increased checking, grooming stress, and sometimes trichotillomania. Clinically, it is useful to assess sleep disruption, major life events, and concomitant depression or anxiety symptoms, because resolving stressors may improve outcomes and adherence to therapy.
Evaluation typically begins with history (onset, rate, triggers, medications, postpartum status, diet, systemic symptoms), scalp examination, and dermoscopy to assess miniaturization, exclamation-point hairs, inflammation, and scale. Trichoscopy may guide differentiation between telogen effluvium and androgenetic alopecia. Laboratory testing is considered when clinically indicated, commonly including complete blood count, ferritin/iron studies, thyroid-stimulating hormone, and sometimes vitamin D, androgen levels, or assessments for nutritional and inflammatory conditions.
Evidence-based management depends on the diagnosis. For telogen effluvium, the cornerstone is identifying and correcting the trigger; regrowth often occurs within months once the follicle cycle normalizes, though supportive nutrition and scalp care are important. For androgenetic alopecia, topical minoxidil (and in many cases oral finasteride for appropriate patients) can prolong anagen and improve density; response varies by time and adherence. For alopecia areata, treatment may include intralesional corticosteroids for limited disease, topical immunotherapy, or systemic therapies in more extensive cases. For inflammatory scalp conditions, anti-inflammatory and antifungal strategies reduce shedding by controlling scalp pathology. If scarring alopecia is suspected, prompt referral to dermatology for biopsy and rapid immunomodulatory treatment is essential.
In all cases, unrealistic expectations should be avoided: hair regrowth is gradual due to follicle cycling timelines. Patients benefit from education about normal daily shedding ranges, the difference between shedding and breakage, and the importance of consistent therapy. With accurate diagnosis and targeted interventions—especially addressing hormonal, inflammatory, nutritional, and stress-related contributors—many forms of hair loss become controllable and, in non-scarring etiologies, potentially reversible. Source: [@SkinBodyRenewal / SkinBodyRenewal]
Skin Renewal SA: Our head of hair is our crowning glory, the thought of losing handfuls of hair is enough to set off the sirens in anyones head. So what could be the causes of fall out? #SkinOnline #SkinOnlineBlog #hair #hairloss #hormones #stress. #breaking
— @SkinBodyRenewal May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
